METTL3 affects FLT3-ITD+ acute myeloid leukemia by mediating autophagy by regulating PSMA3-AS1 stability-Reference-Cited by-同舟云学术

METTL3 affects FLT3-ITD+ acute myeloid leukemia by mediating autophagy by regulating PSMA3-AS1 stability

Published:2023-04-23 Issue:10 Volume:22 Page:1232-1245
ISSN:1538-4101
Container-title:Cell Cycle
language:en
Short-container-title:Cell Cycle

Author:

Wu Shenghao¹,Weng Shanshan¹,Zhou Wenjin¹,Chen Yuemiao¹,Liu Zhen¹

Affiliation:

1. Department of Hematology, The Dingli Clinical Institute of Wenzhou Medical University (The Second Affiliated Hospital of Shanghai University , Wenzhou Central Hospital), Wenzhou, Zhejiang Province, China

Funder

Basic Public Welfare Research Project of Zhejiang Province

CSCO-Qilu cancer research fund project

Publisher

Informa UK Limited

Subject

Cell Biology,Developmental Biology,Molecular Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384101.2023.2204770

Reference27 articles.

1. Serine Biosynthesis Is a Metabolic Vulnerability in FLT3-ITD–Driven Acute Myeloid Leukemia

2. Maintenance therapy for FLT3-ITD-mutated acute myeloid leukemia

3. Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens

4. FLT3-ITD allelic ratio and HLF expression predict FLT3 inhibitor efficacy in adult AML

5. FLT3 tyrosine kinase inhibitors synergize with BCL-2 inhibition to eliminate FLT3/ITD acute leukemia cells through BIM activation

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in the reciprocal regulation of m6A modification with non-coding RNAs and its therapeutic application in acute myeloid leukemia;Pharmacology & Therapeutics;2024-07

2. METTL3's role in cervical cancer development through m⁶A modification;The FASEB Journal;2024-05-29

3. Small molecule inhibitors targeting m6A regulators;Journal of Hematology & Oncology;2024-05-06

4. Unveiling autophagy complexity in leukemia: The molecular landscape and possible interactions with apoptosis and ferroptosis;Cancer Letters;2024-02